ArticleLiver international : official journal of the International Association for the Study of the Liver2026

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.

Jung Sun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.